Updated
Updated · NBC News · Jul 17Doctor Prescribes 31-Year-Old Brandon Chargoy Semaglutide After Type 2 Diabetes Diagnosis
1 articles · Updated · NBC News · Jul 17Summary
- Brandon Chargoy, 31, was prescribed semaglutide after doctors diagnosed him with Type 2 diabetes.
- That prescription followed years of weight struggles, with Chargoy cycling through crash diets and fitness fads without lasting success.
- The diagnosis marked a turning point, shifting his treatment from repeated self-directed weight-loss efforts to a doctor-led medication plan.
Insights
Beyond weight loss, what are the unknown health consequences of lifelong reliance on these new drugs? With monthly costs over $1,000, will miracle weight-loss drugs create a new health equity crisis? As GLP-1s become a first-line defense, are we medicating a societal problem instead of fixing it?